Effect of CGA for Frail Elderly Patients Operated for Colorectal Cancer - The CRC Frailty-study
Colorectal Neoplasms, Frailty, CGA
About this trial
This is an interventional treatment trial for Colorectal Neoplasms focused on measuring Frailty, Elderly, Colorectal cancer, Comprehensive Geriatric Assessment
Eligibility Criteria
Inclusion Criteria:
- Potentially curable colorectal cancer (according to cTNM)
- ≥ 70 years old
- Frailty (CFS-9 v2.0 score 4-8)
Exclusion Criteria:
- Palliative situation
- Unable to understand study information
- Acute surgery
- Terminally ill patient (CFS-9 9)
- Less than 6 months expected survival
- Not willing to participate
Sites / Locations
- Sahlgrenska University HospitalRecruiting
- Department of Surgery, NU-Hospital/NÄLRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention group
Control group
The patients in the intervention arm will receive the same care and treatment as is provided to all patients in the clinical setting, including the ERAS-concept. In addition to this they will be individually assessed by a physician with geriatric profile, dietician, physiotherapist and nurse and thereafter undergo appropriate interventions (CGA and care). The intervention team will have weekly meetings regarding the patients included in the study to evaluate how long the intervention should continue before surgery, a maximum time of eight weeks will be allowed for the intervention.
The patients in the control group will standard care and treatment which include assessment of surgeons, anaesthesiologists and, if needed, other specialized physicians. They will be treated according to the ERAS-concept in the pre- peri- and post operative phase.